Discovering new antibacterial drugs from beneficial bacteria
Microbial Ecology-Guided Discovery of Antibacterial Drugs
This study is looking for new antibiotics from friendly bacteria that live in animals, hoping to find safe and effective treatments for tough infections that don't respond to regular medicines.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Utah NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project ID | NIH-11010015 on NIH RePORTER |
What this research studies
This research focuses on identifying new antibacterial agents derived from symbiotic bacteria that live in animal hosts. By studying these bacteria, the project aims to find compounds that can effectively target harmful bacteria while being safe for human use. The approach involves cultivating these bacteria and analyzing the natural products they produce, which may have the potential to combat multidrug-resistant infections. The research seeks to improve the drug discovery process by ensuring that the compounds are selective and less toxic to humans.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from infections caused by antibiotic-resistant bacteria.
Not a fit: Patients with infections that are not caused by multidrug-resistant bacteria may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new, effective treatments for infections caused by multidrug-resistant bacteria.
How similar studies have performed: Other research has shown promise in discovering antibacterial agents from natural products, indicating that this approach could be effective.
Where this research is happening
Salt Lake City, United States
- University of Utah — Salt Lake City, United States (Active)
Researchers
- Principal investigator: Schmidt, Eric W — University of Utah
- Study coordinator: Schmidt, Eric W
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.